DH

David F. Hendren

Chief Business Officer at iMetabolic Biopharma Corporation

Mr. David F. Hendren is the Chief Business Officer. Mr. Hendren has 25+ years of experience in building, funding and launching healthcare, life sciences and bio-medically related companies. He has participated in companies that were able to execute IPO, M&A and licensing exit strategies that have a cumulative total that exceeds over $1 Billion.


Org chart